Literature DB >> 32265408

Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada.

Norberto Rodriguez-Baez1, Karen F Murray2, David E Kleiner3, Simon C Ling4, Philip Rosenthal5, Kristen Carlin6, Kara Cooper6, Kathleen B Schwarz7, Sarah J Schwarzenberg8, Jeffrey H Teckman9, Marc G Ghany10, Ahmad Samer Alawad10.   

Abstract

OBJECTIVES: Chronic hepatitis B virus infection is a major cause of morbidity and mortality. The aim of the study is to describe the hepatic histology in children chronically infected with hepatitis B virus living in the United States and Canada.
METHODS: Liver biopsies of 134 treatment-naïve children with chronic hepatitis B virus infection were scored for inflammation, fibrosis, and other histological features, and correlated with clinical and laboratory data.
RESULTS: Sixty percentage of subjects acquired the infection vertically, 51% were male, and 69% were hepatitis B e antigen-positive at the time of the biopsy. Hepatitis B DNA levels were generally high (mean 7.70 log IU/mL), as was serum alanine aminotransferase (median 120 U/L). Using the Ishak-modified histology activity index scoring system, interface hepatitis was mild in 31%, moderate in 61%, and severe in 6%. Lobular inflammation was mild in 54%, moderate in 29%, and marked in 7%. Portal inflammation was mild in 38% and moderate in 62% of subjects. Eighteen percentage had no fibrosis, 59% had portal expansion without bridging fibrosis, 19% had bridging fibrosis, and 4% had cirrhosis. Alanine aminotransferase positively correlated with inflammation and fibrosis. Neither age, duration of infection, nor Hepatitis B virus DNA levels correlated with fibrosis. Fibrosis-4 index did not correlate with fibrosis but correlated with inflammation. Aspartate aminotransferase/platelet ratio index correlated with both inflammation and fibrosis.
CONCLUSIONS: Chronic hepatitis B virus infection results in significant inflammation and fibrosis during childhood. Serum alanine aminotransferase is a strong indicator of the severity and extent of hepatic inflammation and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32265408      PMCID: PMC8491712          DOI: 10.1097/MPG.0000000000002712

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   3.288


  21 in total

1.  Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia.

Authors:  Sang Yong Kim; Jae Yeon Seok; Seok Joo Han; Hong Koh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-08       Impact factor: 2.839

2.  Estimating the global prevalence of hepatitis B.

Authors:  Jennifer H MacLachlan; Stephen Locarnini; Benjamin C Cowie
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

3.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

4.  Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.

Authors:  Katherine E McGoogan; P Brian Smith; Steve S Choi; Wallace Berman; Ravi Jhaveri
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

5.  Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Stuart McPherson; Stephen F Stewart; Elsbeth Henderson; Alastair D Burt; Christopher P Day
Journal:  Gut       Date:  2010-09       Impact factor: 23.059

6.  Long-term outcome in children with chronic hepatitis B: a 24-year observation period.

Authors:  Raffaele Iorio; Antonietta Giannattasio; Francesco Cirillo; Luca D' Alessandro; Angela Vegnente
Journal:  Clin Infect Dis       Date:  2007-09-07       Impact factor: 9.079

7.  Aspartate Aminotransferase-to-Platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation.

Authors:  Andrew Grieve; Erica Makin; Mark Davenport
Journal:  J Pediatr Surg       Date:  2013-04       Impact factor: 2.545

8.  Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Authors:  Zachary D Goodman; Hala R Makhlouf; Lea Liu; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Patricia R Robuck; Kathleen B Schwarz
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

9.  Children with Chronic Hepatitis B in the United States and Canada.

Authors:  Kathleen B Schwarz; Yona Keich Cloonan; Simon C Ling; Karen F Murray; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Lilia Ganova-Raeva; Philip Rosenthal
Journal:  J Pediatr       Date:  2015-09-10       Impact factor: 4.406

10.  Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.

Authors:  Marc G Ghany; Robert Perrillo; Ruosha Li; Steven H Belle; Harry L A Janssen; Norah A Terrault; Margaret C Shuhart; Daryl T-Y Lau; W Ray Kim; Michael W Fried; Richard K Sterling; Adrian M Di Bisceglie; Steven-Huy B Han; Lilia Milkova Ganova-Raeva; Kyong-Mi Chang; Anna Suk-Fong Lok
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-08       Impact factor: 11.382

View more
  1 in total

1.  Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada.

Authors:  Simon C Ling; Hsing-Hua S Lin; Karen F Murray; Philip Rosenthal; Douglas Mogul; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Kathleen B Schwarz
Journal:  J Pediatr       Date:  2021-05-20       Impact factor: 6.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.